Literature DB >> 16231054

Real-time quantitative PCR for the design of lentiviral vector analytical assays.

C Delenda1, C Gaillard.   

Abstract

From the recent and emerging concerns for approving lentiviral vector-mediated gene transfer in human clinical applications, several analytical methods have been applied in preclinical models to address the lentiviral vector load in batches, cells or tissues. This review points out the oldest generation methods (blots, RT activity, standard PCR) as well as a full description of the newest real-time quantitative PCR (qPCR) applications. Combinations of primer and probe sequences, which have worked in the lentiviral amplification context, have been included in the effort to dress an exhaustive list. Also, great variations have been observed from interlaboratory results, we have tempted to compare between them the different analytical methods that have been used to consider (i) the titration of lentiviral vector batches, (ii) the absence of the susceptible emerging replicative lentiviruses or (iii) the lentiviral vector biodistribution in the organism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16231054     DOI: 10.1038/sj.gt.3302614

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  15 in total

1.  A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation Status.

Authors:  Floriane Fusil; Sara Calattini; Fouzia Amirache; Jimmy Mancip; Caroline Costa; Justin B Robbins; Florian Douam; Dimitri Lavillette; Mansun Law; Thierry Defrance; Els Verhoeyen; François-Loïc Cosset
Journal:  Mol Ther       Date:  2015-08-18       Impact factor: 11.454

Review 2.  Recombinant lentivector as a genetic immunization vehicle for antitumor immunity.

Authors:  Yukai He; David Munn; Louis D Falo
Journal:  Expert Rev Vaccines       Date:  2007-12       Impact factor: 5.217

3.  Super-rapid quantitation of the production of HIV-1 harboring a luminescent peptide tag.

Authors:  Seiya Ozono; Yanzhao Zhang; Minoru Tobiume; Satoshi Kishigami; Kenzo Tokunaga
Journal:  J Biol Chem       Date:  2020-07-20       Impact factor: 5.157

4.  Adenoviral protein V promotes a process of viral assembly through nucleophosmin 1.

Authors:  Hideyo Ugai; George C Dobbins; Minghui Wang; Long P Le; David A Matthews; David T Curiel
Journal:  Virology       Date:  2012-06-18       Impact factor: 3.616

5.  Glutathione S-transferases promote proinflammatory astrocyte-microglia communication during brain inflammation.

Authors:  Shin-Ichi Kano; Eric Y Choi; Eisuke Dohi; Swati Agarwal; Daniel J Chang; Ashley M Wilson; Brian D Lo; Indigo V L Rose; Santiago Gonzalez; Takashi Imai; Akira Sawa
Journal:  Sci Signal       Date:  2019-02-19       Impact factor: 8.192

6.  Effect of inactivating RNA viruses by coupled UVC and UVA LEDs evaluated by a viral surrogate commonly used as a genetic vector.

Authors:  Yun Zhao; Jianfei Dong
Journal:  Biomed Opt Express       Date:  2022-07-28       Impact factor: 3.562

7.  Changes in the accessibility of the HIV-1 Integrase C-terminus in the presence of cellular proteins.

Authors:  Sofia Benkhelifa-Ziyyat; Stéphanie Bucher; Maria-Antonietta Zanta-Boussif; Julie Pasquet; Olivier Danos
Journal:  Retrovirology       Date:  2010-04-05       Impact factor: 4.602

Review 8.  Gene delivery by lentivirus vectors.

Authors:  Adam S Cockrell; Tal Kafri
Journal:  Mol Biotechnol       Date:  2007-07       Impact factor: 2.860

9.  Highly efficient concentration of lenti- and retroviral vector preparations by membrane adsorbers and ultrafiltration.

Authors:  Katrin Zimmermann; Oliver Scheibe; Andreas Kocourek; Jutta Muelich; Elke Jurkiewicz; Alexander Pfeifer
Journal:  BMC Biotechnol       Date:  2011-05-20       Impact factor: 2.563

10.  Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors.

Authors:  Jolien Vermeire; Evelien Naessens; Hanne Vanderstraeten; Alessia Landi; Veronica Iannucci; Anouk Van Nuffel; Tom Taghon; Massimo Pizzato; Bruno Verhasselt
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.